[{"AccountsPayableCurrent_0_Q1_USD":389000000.0,"ImpairmentOfIntangibleAssetsExcludingGoodwill_1_Q1_USD":0.0,"RealizedInvestmentGainsLosses_1_Q1_USD":-77300000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q1_USD":-18900000.0,"AccruedIncomeTaxesNoncurrent_0_Q1_USD":801300000.0,"AccruedRoyaltiesCurrent_0_Q1_USD":209900000.0,"AllocatedShareBasedCompensationExpenseNetOfTax_1_Q1_USD":76400000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":7700000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":16100000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":2247000000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":2238600000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":1269100000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q1_USD":147300000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q1_USD":194200000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":-335100000.0,"ConstructionPayableCurrentAndNoncurrent_0_Q1_USD":27300000.0,"DebtInstrumentFairValue_0_Q1_USD":6681300000.0,"DebtSecuritiesAvailableForSaleRealizedGain_1_Q1_USD":5700000.0,"ProceedsFromPaymentsForOtherFinancingActivities_1_Q1_USD":4500000.0,"DebtSecuritiesAvailableForSaleRealizedLoss_1_Q1_USD":19100000.0,"PaymentsToAcquireOtherProductiveAssets_1_Q1_USD":0.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":190300000.0,"AvailableForSaleSecurities_0_Q1_USD":2238600000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q1_USD":1379100000.0,"IncomeLossFromEquityMethodInvestments_1_Q1_USD":-14800000.0,"OtherAssetsCurrent_0_Q1_USD":683800000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_0_Q1_USD":846000000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_Q1_USD":856300000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0_Q1_USD":1269100000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q1_USD":1267700000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q1_USD":969500000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":2591300000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":-63900000.0,"OtherLiabilitiesCurrent_0_Q1_USD":2437800000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":3446900000.0,"PaymentsForProceedsFromOtherInvestingActivities_1_Q1_USD":500000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":-69200000.0,"StockholdersEquityOther_1_Q1_USD":600000.0,"EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_1_Q1_pure":-0.041,"OtherLiabilitiesNoncurrent_0_Q1_USD":1357300000.0,"DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown_1_Q1_USD":0.0,"EffectiveIncomeTaxRateReconciliationDispositionOfAssets_1_Q1_pure":0.0,"EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization_1_Q1_pure":0.002,"OperatingLeaseRightOfUseAsset_0_Q1_USD":422000000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q1_USD":-7800000.0,"OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_1_Q1_USD":700000.0,"OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_1_Q1_USD":33800000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1_Q1_USD":-800000.0,"OtherNoncashIncomeExpense_1_Q1_USD":-45700000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":29600000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":1684700000.0,"PaymentsToAcquireInProcessResearchAndDevelopment_1_Q1_USD":75000000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":2389300000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesEquity_1_Q1_USD":500000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1_Q1_USD":-14800000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q1_USD":476300000.0,"ResearchAndDevelopmentInProcess_1_Q1_USD":75000000.0,"RestructuringCharges_1_Q1_USD":0.0,"ServicingAssetAtFairValueChangesInFairValueResultingFromChangesInValuationInputsOrChangesInAssumptions_1_Q1_USD":0.0,"TaxBasisOfInvestmentsCostForIncomeTaxPurposes_0_Q1_USD":0.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":403700000.0,"NumberOfReportableSegments_1_Q1_segment":1.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":475200000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":210900000.0,"EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_1_Q1_pure":0.002,"EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_1_Q1_USD":1500000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1_Q1_USD":13300000.0,"EquitySecuritiesFvNiGainLoss_1_Q1_USD":-60900000.0,"EquitySecuritiesFvNiRealizedGainLoss_1_Q1_USD":0.0,"EquitySecuritiesFvNiUnrealizedGainLoss_1_Q1_USD":-60900000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_1_Q1_USD":4600000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q1_USD":220000000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q1_shares":300000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":193000000.0,"GoodwillImpairedAccumulatedImpairmentLoss_0_Q1_USD":0.0,"GoodwillOtherIncreaseDecrease_1_Q1_USD":-5800000.0,"IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_1_Q1_USD":0.0,"IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsAttributableToParentBeforeIncomeTax_1_Q1_USD":0.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_1_Q1_USD":223000000.0,"IncreaseDecreaseInEquitySecuritiesFvNi_1_Q1_USD":-62000000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_1_Q1_USD":-18500000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q1_USD":8399800000.0,"GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_1_Q1_USD":2400000.0,"TranslationAdjustmentForNetInvestmentHedgeNetOfTaxPeriodIncreaseDecrease_1_Q1_USD":23000000.0,"TreasuryStockValue_0_Q1_USD":2977100000.0,"EarningsPerShareDiluted_1_Q1_USD":8.08,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":149700000.0,"ProfitLoss_1_Q1_USD":1392600000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":3281600000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":15673100000.0,"Revenues_1_Q1_USD":3534300000.0,"StockholdersEquity_0_Q1_USD":12546900000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0005,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1_Q1_pure":0.21,"EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_1_Q1_pure":0.006,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":4952900000.0,"InterestExpense_1_Q1_USD":44300000.0,"NotesPayableCurrent_0_Q1_USD":1501800000.0,"OperatingIncomeLoss_1_Q1_USD":1819900000.0,"PaymentsForRepurchaseOfCommonStock_1_Q1_USD":2220200000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"PreferredStockValue_0_Q1_USD":0.0,"NetIncomeLoss_1_Q1_USD":1399100000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":570100000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":1467300000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-2245300000.0,"AccountsReceivableNetCurrent_0_Q1_USD":2092600000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-149300000.0,"AdditionalPaidInCapital_0_Q1_USD":100000.0,"AssetImpairmentCharges_1_Q1_USD":0.0,"Assets_0_Q1_USD":26119200000.0,"AssetsCurrent_0_Q1_USD":8007200000.0,"CommonStockValue_0_Q1_USD":100000.0,"CostsAndExpenses_1_Q1_USD":1714400000.0,"Depreciation_1_Q1_USD":48400000.0,"EffectOfExchangeRateOnCashAndCashEquivalents_1_Q1_USD":12700000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":292000000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":238400000.0,"IncreaseDecreaseInDueFromRelatedParties_1_Q1_USD":-78600000.0,"InventoryNet_0_Q1_USD":858800000.0,"Liabilities_0_Q1_USD":13582300000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":26119200000.0,"LiabilitiesCurrent_0_Q1_USD":4638600000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":442900000.0,"ShareBasedCompensation_1_Q1_USD":67700000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":-47800000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":173100000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":172800000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-347400000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":662000000.0,"PaymentsToAcquireIntangibleAssets_1_Q1_USD":37000000.0,"CashEquivalentsAtCarryingValue_0_Q1_USD":1974100000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":1385000000.0,"NotesPayable_0_Q1_USD":5961700000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q1_USD":-5900000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-13500000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":-14100000.0,"TaxesPayableCurrent_0_Q1_USD":310000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":1699400000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":3109400000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":36900000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":119900000.0,"EffectiveIncomeTaxRateReconciliationTaxCredits_1_Q1_pure":0.01,"InvestmentIncomeInterest_1_Q1_USD":24400000.0,"StockIssuedDuringPeriodValueTreasuryStockReissued_1_Q1_USD":18100000.0,"OtherAssetsNoncurrent_0_Q1_USD":1130600000.0,"NonoperatingIncomeExpense_1_Q1_USD":-120500000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q1_USD":-6500000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":1636700000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":71500000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":2722800000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.172,"EffectiveIncomeTaxRateReconciliationOtherAdjustments_1_Q1_pure":-0.003,"IncreaseDecreaseInInventories_1_Q1_USD":62200000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_1_Q1_USD":0.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-4400000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":172700000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":12536900000.0,"EarningsPerShareBasic_1_Q1_USD":8.1,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q1_USD":220000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q1_USD":230000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q1_USD":230000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":220000000.0,"Goodwill_0_Q1_USD":5752000000.0,"LongTermDebt_0_Q1_USD":4459900000.0,"MinorityInterest_0_Q1_USD":-10000000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":454300000.0,"ValuationAllowancesAndReservesBalance_0_Q1_USD":1281800000.0,"Ticker":"BIIB","CIK":"875045","name":"BIOGEN INC.","OfficialName":"Biogen Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"32775642095.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20200423"}]